101 related articles for article (PubMed ID: 6052326)
1. Cephaloridine in septic shock: report on 5 cases with an experimental study.
McAllister TA; Wright CJ
Postgrad Med J; 1967 Aug; 43():Suppl 43:154-7. PubMed ID: 6052326
[No Abstract] [Full Text] [Related]
2. [Phentolamine in the treatment of septic shock].
Jacob E; Gassner S; Shapira Z
Harefuah; 1972 Sep; 83(5):189-94. PubMed ID: 4652885
[No Abstract] [Full Text] [Related]
3. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
[TBL] [Abstract][Full Text] [Related]
4. Is experimental endotoxaemia in humans suitable for simulating antibiotic pharmacokinetics in sepsis and septic shock? A pilot study using the model compound fosfomycin.
Sauermann R; Mayer-Helm BX; Petsch M; Popovic M; Thallinger C; Joukhadar C
Int J Antimicrob Agents; 2008 Mar; 31(3):291-2. PubMed ID: 18160265
[No Abstract] [Full Text] [Related]
5. [Short term effects of hypertonic saline during severe sepsis and septic shock].
Muller L; Lefrant JY; Jaber S; Louart G; Mahamat A; Ripart J; de La Coussaye JE; Eledjam JJ
Ann Fr Anesth Reanim; 2004 Jun; 23(6):575-80. PubMed ID: 15234722
[TBL] [Abstract][Full Text] [Related]
6. Albumin changes during clinical septic shock.
Deysine M; Lieblich N; Aufses AH
Surg Gynecol Obstet; 1973 Sep; 137(3):475-8. PubMed ID: 4721522
[No Abstract] [Full Text] [Related]
7. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
[TBL] [Abstract][Full Text] [Related]
8. [Clinical trials with cephaloridine (Ceporin)].
Rohner R; Gubler R; Wyss F
Schweiz Med Wochenschr; 1967 Nov; 97(45):1506-12. PubMed ID: 4875894
[No Abstract] [Full Text] [Related]
9. [Antithrombin III in severe sepsis and septic shock].
Carrillo-Esper R; Núñez-Monroy FN
Gac Med Mex; 1999; 135(4):443-6. PubMed ID: 10491905
[No Abstract] [Full Text] [Related]
10. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
Wilson SJ; Mehta SS; Bellamy MC
Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
[TBL] [Abstract][Full Text] [Related]
11. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
12. Lipid unites disparate syndromes of sepsis.
Wang H; Czura CJ; Tracey KJ
Nat Med; 2004 Feb; 10(2):124-5. PubMed ID: 14760415
[No Abstract] [Full Text] [Related]
13. Antithrombin replacement in patients with sepsis and septic shock.
Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
[TBL] [Abstract][Full Text] [Related]
14. Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.
Oliveira NS; Silva VR; Castelo JS; Elias-Neto J; Pereira FE; Carvalho WB
Pediatr Crit Care Med; 2008 Jul; 9(4):414-7. PubMed ID: 18843251
[TBL] [Abstract][Full Text] [Related]
15. Sepsis and septic shock: selection of empiric antimicrobial therapy.
Cunha BA
Crit Care Clin; 2008 Apr; 24(2):313-34, ix. PubMed ID: 18361948
[TBL] [Abstract][Full Text] [Related]
16. Septic shock.
Ridley M; Phillips I; Eykyn S
Br Med J; 1970 Jan; 1(5690):236. PubMed ID: 5197917
[No Abstract] [Full Text] [Related]
17. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Jacobs S; Price Evans DA; Tariq M; Al Omar NF
Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
[TBL] [Abstract][Full Text] [Related]
18. [Human recombinant activated protein C in patients with severe sepsis and septic shock].
Segal E
Harefuah; 2002 Feb; 141(2):130-1. PubMed ID: 11905079
[No Abstract] [Full Text] [Related]
19. Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock.
Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Perrella S; Cappannoli A; Mazzarino V; Tosi A; Novelli G; Rossi M; Ginanni Corradini S; Ferretti G; Berloco PB; Pietropaoli P
Transplant Proc; 2007; 39(6):1953-5. PubMed ID: 17692664
[TBL] [Abstract][Full Text] [Related]
20. [Corticosteroids in sepsis and in shock following sepsis].
Weiss Y; Edelman L; Sprung C
Harefuah; 1994 Sep; 127(5-6):188-91. PubMed ID: 7995592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
